ICON Public (NASDAQ:ICLR) Issues FY 2025 Earnings Guidance

ICON Public (NASDAQ:ICLR) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 13.000-15.000 for the period, compared to the consensus estimate of 14.930. The company issued revenue guidance of $8.1 billion-$8.7 billion, compared to the consensus revenue estimate of $8.5 billion. ICON Public also updated its FY 2024 guidance to 13.900-14.100 EPS.

Wall Street Analysts Forecast Growth

ICLR has been the subject of several research reports. TD Cowen lowered their price objective on shares of ICON Public from $369.00 to $285.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Leerink Partners reiterated an “outperform” rating and issued a $255.00 target price (down from $270.00) on shares of ICON Public in a report on Tuesday, November 19th. Truist Financial reaffirmed a “buy” rating and issued a $284.00 price target (down previously from $295.00) on shares of ICON Public in a research report on Wednesday, December 18th. Leerink Partnrs raised shares of ICON Public to a “strong-buy” rating in a report on Wednesday, September 18th. Finally, Robert W. Baird cut their price target on ICON Public from $249.00 to $225.00 and set a “neutral” rating on the stock in a report on Wednesday, November 20th. Four analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, ICON Public currently has a consensus rating of “Moderate Buy” and a consensus price target of $287.00.

ICON Public Price Performance

Shares of NASDAQ ICLR opened at $217.99 on Tuesday. ICON Public has a fifty-two week low of $183.38 and a fifty-two week high of $347.72. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.34 and a current ratio of 1.34. The company has a market cap of $17.98 billion, a PE ratio of 24.30, a P/E/G ratio of 1.54 and a beta of 1.20. The business has a 50-day simple moving average of $211.31 and a two-hundred day simple moving average of $270.81.

ICON Public (NASDAQ:ICLR) last released its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share for the quarter, missing the consensus estimate of $3.72 by ($0.37). ICON Public had a return on equity of 11.91% and a net margin of 9.00%. The company had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same period in the prior year, the firm posted $3.10 EPS. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. As a group, equities analysts expect that ICON Public will post 13.42 EPS for the current fiscal year.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.